5-Aza-2′-deoxycytidine upregulates caspase-9 expression cooperating with p53-induced apoptosis in human lung cancer cells

Oncogene

Volumn 23, Issue 40, 2004, Pages 6779-6787

  Gomyo, Yoshihito ^a   Sasaki, Ji Ichiro ^a   Branch, Cynthia ^a   Roth, Jack A ^a   Mukhopadhyay, Tapas ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b PANJAB UNIVERSITY   (India)

Author keywords

5 aza 2 deoxycytidine; Apoptosis; Caspase 9; Lung tumor; p53

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ADENOVIRUS VECTOR; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BENZYLOXYCARBONYLLEUCYLGLUTAMYLHISTIDYLASPARTYL FLUOROMETHYL KETONE; CASPASE 9; CASPASE INHIBITOR; CISPLATIN; CYTOCHROME C; MESSENGER RNA; PACLITAXEL; PROCASPASE 9; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG ACCUMULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LOW DRUG DOSE; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RNA ANALYSIS; WILD TYPE;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; AZACITIDINE; CASPASE 9; CASPASES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

ADENOVIRIDAE;

EID: 4644275854     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207381     Document Type: Article

References (35)

1. Ammanamanchi S, Kim SJ, Sun LZ and Brattain MG. (1998). J. Biol. Chem., 273, 16527-16534.
2. Ammanamanchi S and Brattain MG. (2001). J. Biol. Chem., 276, 32854-32859.
3. Bender CM, Pao MM and Jones PA. (1998). Cancer Res., 58, 95-101.
4. Charache S, Dover G, Smith K, Talbot Jr CC, Moyer M and Boyer S. (1983). Proc. Natl. Acad. Sci. USA, 80, 4842-4846.
5. Debatin KM. (2000). Toxicol. Lett., 112-113, 41-48.
6. Doerfler W. (1983). Annu. Rev. Biochem., 52, 93-124.
7. Fulda S, Kufer MU, Meyer E, Valen F, Dockhorn-Dworniczak B and Debatin KM. (2001). Oncogene, 20, 5865-5877.
8. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D and Baylin SB. (1995). Cancer Res., 55, 4525-4530.
9. Jackson-Grusby L, Beard C, Possemoto R, Tudor M, Fambrough D, Csankovszki G, Dausman J, Lee P, Wilson C, Lander E and Jaenisch R. (2001). Nat. Genet., 27, 31-39.
10. Johnstone RW, Ruefli AA and Lowe SW. (2002). Cell, 108, 153-164.
11. Jones PA and Laird PW. (1999). Nat. Genet., 21, 163-167.
12. Jones PA. (1996). Cancer Res., 56, 2463-2467.
13. Jordan P and Carmo-Fonseca M. (2000). Cell Mol. Life Sci., 57, 1229-1235.
14. Kano Y, Akutsu M, Tsunoda S, Mori K, Suzuki K and Adachi KI. (1998). Cancer Chemother. Pharmacol., 42, 91-98.
15. Karpf AR, Moore BE, Ririe TO and Jones DA. (2001). Mol. Pharmacol., 59, 751-757.
16. Kataoka M, Wiehle S, Spitz F, Schumacher G, Roth JA and Cristiano RJ. (2000). Oncogene, 19, 1589-1595.
17. Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C, Karasuyama H, Su MS, Rakic P and Flavell RA. (1998). Cell, 94, 325-337.
18. Lapidus RG, Ferguson AT, Ottaviano YL, Parl FF, Smith HS, Weitzman SA, Baylin SB, Issa JJ and Davidson NE. (1996). Clin. Cancer Res., 2, 805-810.
19. Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, Hsieh WS, Isaacs WB and Nelson WG. (1994). Proc. Natl. Acad. Sci. USA, 91, 11733-11737.
20. Lenzi R, Raber MN, Gravel D, Frost P and Abbruzzese JL. (1995). Int. J. Oncol., 6, 447-450.
21. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P and Moll UT. (2003). Mol. Cell, 11, 577-590.
22. Moroni MC, Hickman ES, Denchi EL, Caprara G, Colli E, Cecconi F, Muller H and Helin K. (2001). Nat. Cell Biol., 3, 552-558.
23. Myeroff LL, Parsons R, Kim SJ, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J and Park K. (1995). Cancer Res., 55, 5545-5547.
24. Nishiyama J, Yi X, Venkatachalam MA and Dong Z. (2001). Biochem. J., 360, 49-56.
25. Nishizaki M, Meyn RE, Levy LB, Atkinson EN, White RA, Roth JA and Ji L. (2001). Clin. Cancer Res., 7, 2887-2897.
26. Ohtani-Fujita N, Fujita T, Aoike A, Osifchin NE, Robbins PD and Sakai T. (1993). Oncogene, 8, 1063-1067.
27. Pinto A, Attadia V, Fusco A, Ferrara F, Spada OA and Di Fiore PP. (1984). Blood, 64, 922-929.
28. Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C and Lowe SW. (2001). Nature, 409, 207-211.
29. Steel GG and Peckham MJ. (1979). Int. J. Radiat. Oncol. Biol. Phys., 5, 85-91.
30. Wang TH, Wang HS and Soong YK. (2000). Cancer, 88, 2619-2627.
31. Wu GS and Ding Z. (2002). Oncogene, 21, 1-8.
32. Yoshida H, Kongr YY, Yoshida R, Elia AJ, Hakem A, Hakem R, Penninger JM and Mak TW. (1998). Cell, 94, 325-337.
33. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T and Hirohashi S. (1995). Proc. Natl. Acad. Sci. USA, 92, 7416-7419.
34. Zhang WW, Fang X, Branch CD, Mazur W, French BA and Roth JA. (1993). Biotechniques, 15, 868-872.
35. Zou H, Henzel WJ, Liu X, Lutschg A and Wang X. (1997). Cell, 90, 405-413.